Safety and Efficacy of THN102 in Patients With Parkinson's Disease and Excessive Daytime Sleepiness

Clinical trial NCT03624920 · COMPLETED

Trial details

NCT number: NCT03624920
Sponsor: Theranexus
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Parkinson Disease

Start date: 2018-07-12
Primary completion: 2019-12-20
Enrollment: 77

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.